1.00494
Parteck® M 100 (Mannitol)
EMPROVE® ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, E 421
別名:
D-Mannitol
サイズを選択してください
この商品について
Quality Level
agency
BP, ChP, JP, Ph. Eur., USP
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
pH
5-7 (20 °C, 100 g/L in H2O)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Features and Benefits
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Uniform doses with homogenous distribution
Legal Information
保管分類
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Emprove®プログラムを使用してGMPを遵守します。
Emprove® Dossiersで資格認定を加速し、コンプライアンスを維持し、時間を節約しましょう。
注意: EmproveSuite.comに移動します。ユーザー名とパスワードはSigmaAldrich.comとは別のもので、異なる場合があります。
無料会員登録すると、数分でEmprove® Dossiersにアクセスできます。 購読プランをアップグレードして、Emprove® Suiteの高度でカスタマイズされたコンテンツをアンロックしてください。
お探しのものが見つかりませんか？Emprove® プログラムのヘルプページをご覧ください。.
資料
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
This article describes the use of excipients to help address API stability issues.
This article describes the advantages of mannitol when used as an excipient in solid drug formulation.
関連コンテンツ
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 1.00494.2500 | 04027269048778 |
| 1.00494.9025 | 04027269146832 |